There's hope that Health Canada's approval of Pfizer's antiviral COVID-19 treatment will help ease the strain on the country's health-care system, as hospitalizations continue their steady climb.
Health Canada should be ready to make an authorization decision about Pfizer's Paxlovid antiviral treatment for COVID-19 in a week to 10 days, chief medical adviser Dr. Supriya Sharma said on Thursday, January 13, 2022.
Canada has delivered about one-quarter of the direct vaccine doses it has promised to help less wealthy countries and can't say when more doses will go out the door.
Health Canada can add a request from Moderna to Pfizer’s pending offer to vaccinate five- to 11-year-olds, as parents and youngsters in Canada already wait weeks longer than children in the United States for first COVID-19 jabs.
Despite ambitious commitments to reduce their greenhouse gas emissions, a new report from the non-profit ClimateVoice reveals that 12 of the U.S.’s largest pro-climate companies are obstructing efforts to pass the Build Back Better Act.
Jennifer Hubert jumped at the opportunity to get her COVID-19 vaccine, but she’s not looking forward to having to make the decision about whether to vaccinate her three-year-old son Jackson.
The first COVID-19 vaccine for kids under 12 could be in front of Health Canada's review team in just days, and Pfizer expects to start shipping a new pediatric formulation of its vaccine shortly after it gets the green light.
